Archive: 11/29/2012

Cancer agency OK'd faulty $11M grant

(AP)—Texas' embattled $3 billion cancer-fighting agency approved an $11 million grant to a biomedical company even though the proposal wasn't reviewed.

Nov 29, 2012
popularity not rated yet | comments 0

Cometriq approved for rare thyroid cancer

(HealthDay)—Cometriq (cabozantinib) has been approved by the U.S. Food and Drug Administration to treat modullary thyroid cancer that has spread to other parts of the body, the agency said Thursday.

Nov 29, 2012
popularity 5 / 5 (1) | comments 0